Recent Updates
Recently added Catalysts

H1 and H2 deep TMS coils

Phase 1

Major Depression | Unknown | Psychiatry |BrainsWay Ltd.|Last Updated: Feb 5, 2009

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedUNCONTROLLED
Total Trials1
Total Enrollment -
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT00445237Evaluation of Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major DepressionPHASE1 COMPLETED -May 1, 2006Mar 1, 2008Feb 5, 20091 Israel
Unlock Drug Trial Details
Study Design & Arms
AllocationRANDOMIZED
MaskingNONE
ModelPARALLEL
PurposeTREATMENT
Interventions
NameTypeDescription
H1 and H2 deep TMS coilsDEVICE -
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — 65 Years
SexALL
Healthy VolunteersNo
Study Sites1

Inclusion Criteria: * Patients diagnosed as suffering from treatment resistant major depression Exclusion Criteria: * Other axis I diagnosis * Risk factors for convulsions * Electroconvulsive therapy (ECT) in the last 9 months * History of drug abuse in the past year

Countries:Israel
Unlock Eligibility Criteria